Novelix Pharmaceuticals Holds Virtual Meeting to Enhance Shareholder Engagement

Overview Novelix Pharmaceuticals Limited held a successful Extra Ordinary General Meeting (EGM) on January 9, 2026, showcasing its commitment to corporate governance and shareholder engagement. The meeting, conducted via video conferencing, allowed for transparent discussions on critical matters while adhering to regulatory standards.

Key Developments

• The EGM started at 3:30 PM and wrapped up at 3:56 PM, with 64 members participating through Video Conferencing and Other Audio-Visual Means (OAVM).
• Mr. Gattu Gnana Prakash chaired the meeting, ensuring that all voices were heard and that the proceedings were well-represented.
• Key leadership figures, including Mr. Venkateshwarlu Pulluru and Independent Director Mr. Janardhan Das Kabra, were present, highlighting the board's active involvement in governance.

Business Impact This meeting reflects Novelix's proactive approach to maintaining strong relationships with its shareholders. By facilitating virtual participation, the company not only complies with regulations but also enhances its transparency and accountability.

Market Context The pharmaceutical sector has been under scrutiny for governance practices, and Novelix's efforts to engage shareholders could position it favorably among investors. As companies increasingly adopt digital platforms for meetings, this move might set a precedent in the industry.

Industry Context With the ongoing evolution in corporate governance standards, companies like Novelix are adapting to ensure they meet shareholder expectations. The shift towards virtual meetings has become more common, especially post-pandemic, as firms seek to balance accessibility with regulatory compliance.

Looking Ahead As Novelix continues to prioritize shareholder engagement, it may explore further digital initiatives to enhance transparency and communication in the future.